MedPlus Health Services Ltd
NSE:MEDPLUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (107.2), the stock would be worth ₹1 852.21 (110% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 51 | ₹880.6 |
0%
|
| 3-Year Average | 107.2 | ₹1 852.21 |
+110%
|
| 5-Year Average | 107.2 | ₹1 852.21 |
+110%
|
| Industry Average | 43.5 | ₹752.15 |
-15%
|
| Country Average | 28.7 | ₹495.89 |
-44%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
₹101.5B
|
/ |
Jan 2026
₹2.1B
|
= |
|
|
₹101.5B
|
/ |
Mar 2026
₹2.1B
|
= |
|
|
₹101.5B
|
/ |
Mar 2027
₹2.5B
|
= |
|
|
₹101.5B
|
/ |
Mar 2028
₹3B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| IN |
|
MedPlus Health Services Ltd
NSE:MEDPLUS
|
105.5B INR | 51 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62.2B ZAR | 19.2 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.9B ZAR | 25 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 29.3 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
974.6B JPY | 22.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
944.5B JPY | 16.9 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 20.2 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 34.3 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28B CNY | 16.4 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
587.3B JPY | 13.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 18.9 |
| Median | 28.7 |
| 70th Percentile | 44.4 |
| Max | 877 228.1 |
Other Multiples
MedPlus Health Services Ltd
Glance View
MedPlus Health Services Ltd., once a nascent venture in India's vast healthcare landscape, has emerged as a formidable player in retail pharmacy, reflecting a trajectory marked by strategic growth and innovation. Founded in 2006 by Dr. Madhukar Gangadi, the company set out with a vision to bridge the gap in quality and accessibility within the pharmaceutical domain. MedPlus capitalized on a straightforward yet powerful business model - creating a wide-reaching network of stores that combine the traditional trust of a neighborhood pharmacy with a technology-driven supply chain. This approach not only ensured the availability of a vast range of pharmaceuticals and health products but also made these essentials more accessible to consumers via competitive pricing. Its brick-and-mortar outlets, coupled with an expansive online platform, enable MedPlus to seamlessly serve a diverse clientele across urban and semi-urban areas. Financially, MedPlus generates revenue primarily through the sale of prescription and over-the-counter medicines, supplements, personal care, and home healthcare products. The company's prowess lies in its hybrid model, utilizing physical stores as local fulfillment centers for its robust e-commerce business, which promises convenience and swift deliveries. By integrating an expansive logistics network and investing in IT infrastructure, MedPlus ensures operational efficiency that reduces lead times and maintains customer satisfaction. Furthermore, its loyalty programs and customer-centric services foster brand allegiance, driving repeat business. This blend of traditional retail strengths with the scalability of digital channels positions MedPlus not just as a retail pharmacy chain, but as a comprehensive health solutions provider, adept at navigating the evolving demands of the healthcare industry.